Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

China · Delayed Price · Currency is CNY

54.83

+6.04 (12.38%)

At close: Aug 4, 2026

Shanghai OPM Biosciences Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	453.39	354.91	297.24	243.12	294.37	212.68
Revenue Growth	50.52%	19.40%	22.26%	-17.41%	38.41%	70.19%
Gross Profit	202.2	172.72	154.9	141.59	187.12	126.69
Operating Income	15.14	22.45	6.46	19.02	89	55.6
Net Income	66.26	41.7	21.05	54.04	105.37	60.39
Earnings Per Share	0.30	0.37	0.18	0.47	1.04	0.70
EPS Growth	112.69%	105.56%	-61.70%	-54.81%	48.57%	415.84%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Culture Medium Products	300.45
CDMO	53.98
Total	354.44

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,823	1,347	1,335	1,484	1,717	350.51
Total Debt	169.78	57	65.34	69.39	91.8	121.72
Net Cash (Debt)	1,654	1,290	1,270	1,414	1,625	228.79
Net Cash Growth	23.67%	1.55%	-10.20%	-12.96%	610.20%	-16.88%
Net Cash Per Share	7.36	11.44	10.86	12.30	16.04	2.65

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	55.41	103.39	69.25	57.95	111.62	114.63
Capital Expenditures	-57.37	-56.07	-120.86	-77.55	-146.96	-105.98
Free Cash Flow	-1.96	47.32	-51.61	-19.59	-35.34	8.64
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.60%	48.67%	52.11%	58.24%	63.57%	59.56%
Operating Margin	3.34%	6.33%	2.17%	7.82%	30.23%	26.14%
Pretax Margin	14.82%	13.91%	12.26%	25.37%	40.57%	32.04%
Profit Margin	14.61%	11.75%	7.08%	22.23%	35.80%	28.40%
FCF Margin	-0.43%	13.33%	-17.36%	-8.06%	-12.01%	4.06%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.430	0.430	0.420	0.440	0.429
Dividend Per Share Growth	-53.49%	2.30%	-4.47%	2.66%	-
Dividend Yield	0.88%	0.88%	1.17%	0.82%	0.60%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	185.85	133.75	197.05	117.18	80.29	-
Forward PE	84.35	55.21	40.23	64.15	-	-
P/FCF Ratio	-	117.85	-	-	-	-
PS Ratio	16.84	15.71	13.96	26.04	28.74	-